Fertility Preservation Strategies in Female Cancer Patients: Current Approaches and Future Directions

Area of Science:

• Gynecologic Oncology
• Reproductive Medicine
• Oncology

Background:

• Fertility-sparing treatments (FSTs) are increasingly vital for young women diagnosed with early-stage gynecological cancers.
• Concerns regarding the long-term oncological safety of FSTs, especially in advanced cancer stages, persist.
• Preserving fertility is a critical consideration for this patient demographic.

Purpose of the Study:

• To review the current literature on fertility-sparing treatments for gynecological cancers.
• To evaluate the reproductive and oncological outcomes of various FSTs.
• To identify areas requiring further research in FSTs for gynecological malignancies.

Main Methods:

• A comprehensive literature review was performed using PubMed, Scopus, and Web of Science databases.
• Search terms included "fertility preservation" and "gynaecological cancer" for articles published between 2014 and 2024.
• Inclusion criteria focused on female patients undergoing FSTs with adequate oncological outcome reporting.

Main Results:

• Radical trachelectomy and cryopreservation techniques (oocyte, ovarian tissue) demonstrate positive reproductive outcomes, with pregnancy rates of 30-50% in early-stage disease.
• Gonadotropin-releasing hormone (GnRH) analogs show promise in maintaining fertility during chemotherapy.
• Minimally invasive and robotic-assisted surgeries offer comparable fertility outcomes with reduced complications.

Conclusions:

• Fertility-sparing treatment is a viable and promising option for women with early-stage gynecological cancers, yielding favorable reproductive and survival rates.
• Long-term oncological safety in advanced stages of gynecological cancer remains an area needing further extensive research.
• Individualized treatment planning and multidisciplinary collaboration are crucial for optimizing patient outcomes in FSTs.